Ramsay Health Care Limited (RMYHY)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Ramsay Health Care Limited (RMYHY) trades at $7.44. Ramsay Health Care Limited operates a network of hospitals and healthcare facilities across multiple countries. Market cap: $6.84B, Sector: Healthcare.
Price live · AI analysis from Mar 18, 2026Analyst Coverage for RMYHY: RMYHY does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates RMYHY against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
RMYHY: 1/1 perspectives are bearish.
How is this calculated? →Ramsay Health Care Limited (RMYHY) Healthcare & Pipeline Overview
Ramsay Health Care Limited, founded in 1964, owns and operates a network of 460 hospitals and healthcare facilities across the Asia Pacific, the United Kingdom, France, and the Nordics, offering comprehensive healthcare services to public and private patients with a focus on geographic diversification.
What Is the Investment Thesis for RMYHY?
Ramsay Health Care Limited presents a mixed investment case. The company's established presence in multiple geographic regions provides diversification and access to different healthcare markets. The aging population and increasing demand for healthcare services are ongoing tailwinds. However, a relatively low profit margin of 1.6% and a high P/E ratio of 30.9 indicate potential valuation concerns. The dividend yield of 2.01% offers some income potential. Future growth will depend on successful expansion into new markets and the ability to improve operational efficiency. Investors should carefully consider the company's financial metrics and competitive landscape before making investment decisions.
Based on FMP financials and quantitative analysis
RMYHY Key Highlights
- Market capitalization of $6.84B indicates a significant presence in the healthcare sector.
- P/E ratio of 30.9 suggests a premium valuation compared to some industry peers.
- Profit margin of 1.6% reflects relatively low profitability, indicating potential areas for improvement.
- Gross margin of 10.6% highlights the difference between revenue and the cost of goods sold.
- Dividend yield of 2.01% provides a modest income stream for investors.
Who Are RMYHY's Competitors?
RMYHY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AMBBY Ambu A/S | $9.70 | +0.00% | $2.58B | 47 |
| AMFPF Amplifon S.p.A. | $11.21 | +0.00% | $2.47B | 38 |
| BUGDF Bumrungrad Hospital Public Company Limited | $4.75 | +0.00% | $3.78B | 46 |
| BUHPF Bumrungrad Hospital Public Company Limited | $5.45 | +0.00% | $4.33B | 47 |
| CAMRF Camurus AB (publ) | $60.00 | -1.66% | $3.60B | 63 |
| HWAIF Healwell AI Inc. | $0.53 | -3.52% | $160.75M | 65 |
| ASSF Assisted 4 Living, Inc. | $1.00 | +0.00% | $45.35M | 63 |
| FTRP Field Trip Health Ltd. | $0.84 | +1.07% | $9.81M | 62 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RMYHY's Key Strengths?
- Diversified geographic presence in multiple countries.
- Comprehensive range of healthcare services.
- Established relationships with healthcare professionals.
- Reputation for high-quality care.
What Are RMYHY's Weaknesses?
- Relatively low profit margin.
- High P/E ratio.
- Exposure to varying healthcare regulations in different countries.
- Dependence on government funding and private insurance payments.
What Could Drive RMYHY Stock Higher?
- Expansion into new geographic markets in the Asia-Pacific region.
- Development of integrated healthcare services to improve patient outcomes.
- Adoption of digital health technologies to enhance patient engagement.
- Potential strategic acquisitions to expand geographic footprint.
- Focus on specialized medical services to attract patients and generate higher revenue.
What Are the Key Risks for RMYHY?
- Rich valuation — a P/E of 30.9 runs well above the Healthcare sector’s ~23x, leaving little room for a miss.
- Intense competition from other healthcare providers.
- Changes in government healthcare policies and regulations.
- Economic downturns that could reduce healthcare spending.
- Rising healthcare costs and insurance premiums.
- Currency fluctuations affecting the value of ADR.
What Are the Growth Opportunities for RMYHY?
- Expansion in Asia-Pacific: The Asia-Pacific region represents a significant growth opportunity for Ramsay Health Care due to its rapidly growing population and increasing healthcare spending. The company can expand its presence in existing markets like Australia and explore new markets in Southeast Asia. The market size for healthcare in the Asia-Pacific region is projected to reach $2.5 trillion by 2028, offering substantial potential for Ramsay Health Care to increase its revenue and market share. Timeline: Ongoing.
- Development of Integrated Healthcare Services: Ramsay Health Care can enhance its service offerings by developing integrated healthcare services that combine hospital care, rehabilitation, and mental health services. This approach can improve patient outcomes and create efficiencies in healthcare delivery. The market for integrated healthcare services is growing as healthcare providers seek to improve coordination of care and reduce costs. Timeline: Ongoing.
- Adoption of Digital Health Technologies: The adoption of digital health technologies, such as telehealth and remote monitoring, presents a growth opportunity for Ramsay Health Care. These technologies can improve access to care, enhance patient engagement, and reduce healthcare costs. The global telehealth market is projected to reach $55 billion by 2027, indicating a significant potential for Ramsay Health Care to leverage digital health technologies. Timeline: Ongoing.
- Strategic Acquisitions: Ramsay Health Care can pursue strategic acquisitions to expand its geographic footprint and service offerings. Acquisitions can provide access to new markets, technologies, and expertise. The healthcare industry is consolidating, creating opportunities for Ramsay Health Care to acquire smaller players and strengthen its competitive position. Timeline: Ongoing.
- Focus on Specialized Medical Services: Ramsay Health Care can focus on providing specialized medical services, such as oncology, cardiology, and orthopedics, to attract patients and generate higher revenue. The demand for specialized medical services is growing as the population ages and the prevalence of chronic diseases increases. By investing in specialized medical equipment and training, Ramsay Health Care can differentiate itself from competitors and capture a larger share of the market. Timeline: Ongoing.
What Opportunities Does RMYHY Have?
- Expansion in Asia-Pacific region.
- Development of integrated healthcare services.
- Adoption of digital health technologies.
- Strategic acquisitions to expand geographic footprint.
What Threats Does RMYHY Face?
- Intense competition from other healthcare providers.
- Changes in government healthcare policies and regulations.
- Economic downturns that could reduce healthcare spending.
- Rising healthcare costs and insurance premiums.
What Are RMYHY's Competitive Advantages?
- Established presence in multiple geographic regions provides diversification.
- Strong relationships with healthcare professionals and government entities.
- Comprehensive range of healthcare services caters to diverse patient needs.
- Reputation for providing high-quality care and patient satisfaction.
What Does RMYHY Do?
Ramsay Health Care Limited, established in 1964, has grown into a multinational healthcare provider operating 460 facilities across the Asia Pacific, the United Kingdom, France, and the Nordics. Founded in Sydney, Australia, the company's initial focus was on providing quality hospital services. Over the decades, Ramsay Health Care has expanded its operations through strategic acquisitions and organic growth, establishing a significant presence in key international markets. The company's core business involves owning and operating hospitals that cater to both public and private patients. These hospitals offer a broad spectrum of medical services, including surgical procedures, general medical care, and specialized treatments. In addition to hospital services, Ramsay Health Care provides a range of healthcare services, such as rehabilitation, mental health care, and diagnostics. The company's geographic diversification allows it to serve diverse patient populations and adapt to varying healthcare regulations and market dynamics. Ramsay Health Care competes with other major healthcare providers in its operating regions, focusing on delivering high-quality care and maintaining strong relationships with healthcare professionals and government entities.
What Products and Services Does RMYHY Offer?
- Owns and operates hospitals for public and private patients.
- Provides a range of healthcare services, including surgical procedures and medical care.
- Operates facilities in the Asia Pacific region.
- Maintains a presence in the United Kingdom.
- Offers healthcare services in France.
- Provides healthcare services in the Nordics.
How Does RMYHY Make Money?
- Generates revenue from hospital services provided to public and private patients.
- Receives payments from government healthcare programs and private insurance companies.
- Offers a range of healthcare services, including surgical procedures, medical care, and specialized treatments.
- Operates a network of hospitals and healthcare facilities in multiple countries.
What Industry Does RMYHY Operate In?
Ramsay Health Care operates within the global healthcare industry, which is experiencing growth driven by aging populations, increasing prevalence of chronic diseases, and technological advancements. The industry is characterized by intense competition among hospital operators, healthcare service providers, and pharmaceutical companies. Market trends include a shift towards value-based care, increased adoption of telehealth, and growing demand for specialized medical services. Ramsay Health Care's diversified geographic presence and comprehensive service offerings position it to capitalize on these trends, but it faces challenges from competitors such as AMBBY and other regional players.
Who Are RMYHY's Key Customers?
- Public patients seeking medical care through government healthcare programs.
- Private patients with private health insurance.
- Healthcare professionals and medical staff who work at Ramsay Health Care facilities.
- Government entities and healthcare organizations that partner with Ramsay Health Care.
Ramsay Health Care Limited (RMYHY) Valuation Context
Valued at $6.84B, RMYHY is classified as a mid-cap stock.
RMYHY Revenue & Earnings Trend
In Q4 2025, RMYHY generated $9.17B in top-line revenue, marking a sequential decrease of 0.9%. The company recorded net income of $157.8M, with diluted EPS of $0.17. Quarter-over-quarter revenue has been mixed, typical for a mid-cap company operating in Healthcare. Across the four most recent quarters, RMYHY averaged $0.08 in diluted EPS.
Company Profile
Ramsay Health Care Limited operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Sydney, AU. The company is led by CEO Natalie Davis. RMYHY has traded publicly since 2021.
ROE 6%Key Financial Metrics
Return on equity for Ramsay Health Care Limited stands at 5.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 1.3%, showing how much profit it generates from its asset base. RMYHY trades at a trailing price-to-earnings ratio of 30.85, above the Healthcare sector average of ~23x. Its free cash flow yield is 7.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.90 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 2.9%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 5/9Financial Health
Ramsay Health Care Limited's Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 2.45 places it in the grey zone, a middle ground that warrants monitoring.
FY2026 estForward Outlook
Wall Street analysts project Ramsay Health Care Limited revenue of about $18.19B for fiscal 2026, with EPS near $0.37. The estimate reflects 7 contributing analysts.
RMYHY Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying indicates confidence in Ramsay's future, suggesting executives believe in the company's growth potential.
- Community sentiment has shifted positively, with discussions highlighting Ramsay's strategic expansions and acquisitions.
- The healthcare sector remains resilient, and Ramsay's diversified services position it well to capitalize on ongoing demand for healthcare.
- Recent partnerships and collaborations have enhanced Ramsay's service offerings, attracting positive attention from investors.
Bear Case
- Concerns over regulatory changes in the healthcare sector have created uncertainty around Ramsay's operational environment.
- Market sentiment has shown caution due to rising operational costs, which could impact profitability in the near term.
- Some community discussions reflect skepticism about Ramsay's ability to maintain growth amid increasing competition in the healthcare space.
- Recent earnings reports have raised questions about revenue growth, leading to bearish sentiment among some investors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $9.17B | $158M | $0.17 |
| Q2 2025 | $9.25B | $129M | $0.14 |
| Q4 2024 | $8.54B | -$105M | -$0.11 |
| Q2 2024 | $8.58B | $130M | $0.14 |
Based on FMP financials and quantitative analysis
RMYHY Latest News
No recent news available for RMYHY.
RMYHY Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for RMYHY.
Price Targets
Wall Street price target analysis for RMYHY.
RMYHY MoonshotScore
What does this score mean?
The MoonshotScore rates RMYHY's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Natalie Davis
CEO
Natalie Davis is the CEO of Ramsay Health Care Limited, a leading global healthcare provider. She is responsible for managing the company's operations across multiple countries and overseeing its strategic direction. Davis has extensive experience in the healthcare industry, having held various leadership positions in hospitals and healthcare organizations. Her expertise includes healthcare management, strategic planning, and operational efficiency. She has a strong track record of driving growth and improving patient outcomes.
Track Record: Under Natalie Davis's leadership, Ramsay Health Care has expanded its presence in key international markets and enhanced its service offerings. She has focused on improving operational efficiency and implementing digital health technologies to enhance patient care. Davis has also led strategic acquisitions to strengthen the company's competitive position and expand its geographic footprint.
Ramsay Health Care Limited ADR Information Unsponsored
An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company that are held by a U.S. depositary bank. RMYHY is an ADR, meaning it allows U.S. investors to invest in Ramsay Health Care Limited, an Australian company, without directly dealing with foreign stock exchanges. The depositary bank holds the actual RMYH shares in Australia, and the ADR trades on the OTC market in the U.S.
- Home Market Ticker: Australian Securities Exchange (ASX), Australia
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: RMYH
RMYHY OTC Market Information
RMYHY trades on the OTC Other tier of the over-the-counter (OTC) market. The OTC market is a decentralized market for securities not listed on a major exchange like the NYSE or NASDAQ. The OTC Other tier represents the lowest tier of the OTC market, encompassing securities that may have limited or no financial disclosure, and may not meet the minimum listing standards of higher tiers. Companies on this tier may be distressed, in bankruptcy, or unwilling to provide regular financial reporting. Investing in securities on the OTC Other tier carries significant risks due to the lack of transparency and regulatory oversight compared to exchange-listed stocks.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of investing in RMYHY.
- Low trading volume and wide bid-ask spread can make it difficult to buy or sell shares.
- Lack of regulatory oversight on the OTC Other tier increases the potential for fraud or manipulation.
- The company may be distressed or in bankruptcy, increasing the risk of financial loss.
- Currency risk associated with investing in a foreign company.
- Verify the company's financial condition and performance through available sources.
- Research the company's management team and their track record.
- Assess the company's competitive position and industry outlook.
- Understand the risks associated with investing in OTC Other stocks.
- Consult with a financial advisor before investing.
- Determine if the company is pink sheet current.
- Confirm the company's legitimacy and compliance with regulations.
- Established presence in multiple geographic regions.
- Comprehensive range of healthcare services.
- Reputation for providing high-quality care.
- ADR status indicates some level of regulatory oversight.
- Operating history since 1964
Ramsay Health Care Limited Healthcare Stock: Key Questions Answered
What does Ramsay Health Care Limited do?
Ramsay Health Care Limited owns and operates a network of hospitals and healthcare facilities across the Asia Pacific, the United Kingdom, France, and the Nordics. The company provides a comprehensive range of healthcare services to both public and private patients, including surgical procedures, medical care, and specialized treatments. Ramsay Health Care's business model involves generating revenue from hospital services provided to patients and receiving payments from government healthcare programs and private insurance companies. The company's geographic diversification and comprehensive service offerings position it as a major player in the global healthcare industry.
What do analysts say about RMYHY stock?
Analyst consensus on RMYHY stock is not readily available due to its OTC listing and limited coverage. However, key valuation metrics such as the P/E ratio of 30.9 and the profit margin of 1.6% suggest potential valuation concerns. Growth considerations include the company's expansion plans in the Asia-Pacific region and its adoption of digital health technologies. Investors should conduct their own due diligence and consider the risks associated with investing in OTC stocks before making any investment decisions. The dividend yield of 2.01% may be attractive to some investors.
What are the main risks for RMYHY?
The main risks for Ramsay Health Care Limited include intense competition from other healthcare providers, changes in government healthcare policies and regulations, economic downturns that could reduce healthcare spending, and rising healthcare costs and insurance premiums. As an OTC stock, RMYHY is also subject to risks associated with limited financial disclosure, low trading volume, and lack of regulatory oversight. Currency fluctuations can also affect the value of the ADR for U.S. investors. Investors should carefully consider these risks before investing in RMYHY.
What are the key factors to evaluate for RMYHY?
Evaluate RMYHY on fundamentals, analyst consensus, and risk factors. P/E: 30.9x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does RMYHY data refresh on this page?
RMYHY prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven RMYHY's recent stock price performance?
Ramsay Health Care Limited (RMYHY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified geographic presence in multiple countries. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider RMYHY overvalued or undervalued right now?
Ramsay Health Care Limited (RMYHY) trades at 30.9x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying RMYHY?
Before investing in Ramsay Health Care Limited (RMYHY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- OTC data may be less reliable than exchange-listed data.
- Analyst coverage may be limited due to OTC listing.